TickrTrends CRL fair value analysis

Charles River Posts Loss In Q2; Increases 2026 Guidance For Revenue, Non-GAAP EPS

rttnews.com · 2026-08-05

Charles River Laboratories International (CRL) reported a second quarter net loss attributable to common shareholders of $1.48 million compared to net income of $52.

Read the full story at rttnews.com →

Is CRL undervalued? See TickrTrends' fair value analysis →